Food and Drug Administration (FDA) Office of Clinical Pharmacology (OCP) – Multi-phase/Multi- site Clinical Studies and Laboratory Support Indefinite Delivery-Indefinite Quantity (IDIQ) Type Contract

The Food and Drug Administration (FDA) Office of Acquisition and Grant Services has awarded a single-award Indefinite Delivery-Indefinite Quantity (IDIQ) contract under solicitation number 75F40124R00064. This commercial services requirement is a 100% small business set-aside (SBA) performed in Texas. The contract is classified under NAICS 541714 for Research and Development in Biotechnology (except Nanobiotechnology) and PSC AJ12 for General Science and Technology R&D Services; General Science and Technology; Applied Research.

The scope of this IDIQ encompasses multi-phase and multi-site clinical studies and laboratory support for the FDA Office of Clinical Pharmacology. The contractor provides the capability to conduct multiple Phase I clinical trials annually, including parallel studies, alongside a full range of services necessary to support these trials and report their results. Authorized task orders issued under this contract vehicle will be Firm-Fixed-Price. Published on September 16, 2025, this award notice identifies Craig Wright as the primary point of contact.